GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » Operating Margin %

Venus Medtech (Hangzhou) (HKSE:02500) Operating Margin % : -102.56% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Venus Medtech (Hangzhou)'s Operating Income for the six months ended in Dec. 2023 was HK$-264.5 Mil. Venus Medtech (Hangzhou)'s Revenue for the six months ended in Dec. 2023 was HK$257.9 Mil. Therefore, Venus Medtech (Hangzhou)'s Operating Margin % for the quarter that ended in Dec. 2023 was -102.56%.

Good Sign:

Venus Medtech (Hangzhou) Inc operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Venus Medtech (Hangzhou)'s Operating Margin % or its related term are showing as below:

HKSE:02500' s Operating Margin % Range Over the Past 10 Years
Min: -847.18   Med: -136.69   Max: -53.92
Current: -116.22


HKSE:02500's Operating Margin % is ranked worse than
78.66% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 0.94 vs HKSE:02500: -116.22

Venus Medtech (Hangzhou)'s 5-Year Average Operating Margin % Growth Rate was 9.10% per year.

Venus Medtech (Hangzhou)'s Operating Income for the six months ended in Dec. 2023 was HK$-264.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-624.6 Mil.

Warning Sign:

Venus Medtech (Hangzhou) Inc has never been profitable in the past 3 years. It lost money every year.


Venus Medtech (Hangzhou) Operating Margin % Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) Operating Margin % Chart

Venus Medtech (Hangzhou) Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -136.69 -53.92 -65.40 -156.20 -116.22

Venus Medtech (Hangzhou) Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -119.98 -111.56 -203.89 -128.82 -102.56

Competitive Comparison of Venus Medtech (Hangzhou)'s Operating Margin %

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Venus Medtech (Hangzhou)'s Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s Operating Margin % distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s Operating Margin % falls into.



Venus Medtech (Hangzhou) Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Venus Medtech (Hangzhou)'s Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-624.634 / 537.453
=-116.22 %

Venus Medtech (Hangzhou)'s Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-264.486 / 257.873
=-102.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Venus Medtech (Hangzhou)  (HKSE:02500) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Venus Medtech (Hangzhou) Operating Margin % Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Venus Medtech (Hangzhou) (HKSE:02500) Business Description

Traded in Other Exchanges
Address
No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051
Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.
Executives
Zeng Min Frank 2201 Interest of corporation controlled by you
Zi Zhenjun 2201 Interest of corporation controlled by you
Ming Zhi Investments (bvi) Limited 2101 Beneficial owner
Ming Zhi Investments Limited 2201 Interest of corporation controlled by you
Qiming Venture Partners Iii, L.p. 2201 Interest of corporation controlled by you
Qiming Corporate Gp Iii, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp Iii, L.p. 2201 Interest of corporation controlled by you
Dcp Capital Partners, L.p. 2201 Interest of corporation controlled by you
Dcp General Partner, Ltd 2201 Interest of corporation controlled by you
Dcp, Ltd. 2201 Interest of corporation controlled by you
Liu Haifeng David 2201 Interest of corporation controlled by you
Muheng Capital Partners (hong Kong) Limited 2101 Beneficial owner
Red Giant Limited 2201 Interest of corporation controlled by you
Wolhardt Julian Juul 2201 Interest of corporation controlled by you
Horizon Binjiang Llc 2101 Beneficial owner

Venus Medtech (Hangzhou) (HKSE:02500) Headlines

No Headlines